| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0024
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-42 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-78 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L15-00 |
| filingDate |
2008-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2010-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2010520860-A |
| titleOfInvention |
Controlled release composition |
| abstract |
The present invention relates to the field of pharmacology. More particularly, the present invention relates to controlled release compositions. The present invention is a controlled release composition comprising cross-linked gelatin and at least one therapeutic protein, wherein the ratio of the average mesh size (ΞΎ) of the gelatin matrix to the average hydrodynamic radius (RH) of the therapeutic protein. It relates to a controlled release composition of less than 2, preferably less than 1.5. [Selection figure] None |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019525990-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2017170487-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019022885-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017170487-A1 |
| priorityDate |
2007-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |